داروسازی امین
دامین | Stocks - Tehran Stock Exchange (TSE)
داروهای شیمیایی و گیاهی
Sector:
داروهای شیمیایی و گیاهی
Market Type:
Stocks
Status:
Authorized
Last Price: 17,280 2.98
Close Price: 17,280
Income Statement
AGM
Interim
2026/02/28 Fiscal Year 2025/12/2112 Month | 2025/07/09 Fiscal Year 2025/03/2012 Month | 2024/06/10 Fiscal Year 2024/03/1912 Month | ||
|---|---|---|---|---|
Revenue from Services & Sales | 8.985 Trillion | 13.216 Trillion | 12.39 Trillion | |
Total Revenues | 8.985 Trillion | 13.216 Trillion | 12.39 Trillion | |
Cost of Goods Sold | 5.25 Trillion | 8.943 Trillion | 7.367 Trillion | |
Gross Profit | 3.735 Trillion | 4.273 Trillion | 5.024 Trillion | |
General & Administrative Expenses | 673.189 Billion | 1.128 Trillion | 666.139 Billion | |
Net Operating Income & Expenses | -57.248 Billion | -10.513 Billion | -29.276 Billion | |
Operating Profit (Loss) | 3.004 Trillion | 3.134 Trillion | 4.328 Trillion | |
Profit Before Tax | 1.058 Trillion | 1.324 Trillion | 3.351 Trillion | |
Tax | 229.342 Billion | 186.85 Billion | 456.16 Billion | |
Net Profit (Loss) After Tax | 828.635 Billion | 1.137 Trillion | 2.895 Trillion | |
Retained Earnings at Beginning of Period | 4.968 Trillion | 4.438 Trillion | 2.522 Trillion | |
Approved Dividends — Prior Year AGM | -115.5 Billion | -550 Billion | -550 Billion | |
Capital Decrease (Increase) from Accumulated Losses (Retained Earnings) | -3.63 Trillion | - | - | |
Allocable Profit | 2.051 Trillion | 5.025 Trillion | 4.868 Trillion | |
Legal Reserve | 41.432 Billion | 56.852 Billion | 144.765 Billion | |
Approved Dividends — Current Year | 173.47 Billion | 115.5 Billion | 550 Billion | |
Retained Earnings at End of Period | 1.836 Trillion | 4.852 Trillion | 4.173 Trillion |